Cavenee WK - Search Results

1

Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity.

Turner KM, Deshpande V, Beyter D, Koga T, Rusert J, Lee C, Li B, Arden K, Ren B, Nathanson DA, Kornblum HI, Taylor MD, Kaushal S, Cavenee WK, Wechsler-Reya R, Furnari FB, Vandenberg SR, Rao PN, Wahl GM, Bafna V, Mischel PS. Turner KM, et al. Among authors: cavenee wk. Nature. 2017 Mar 2;543(7643):122-125. doi: 10.1038/nature21356. Epub 2017 Feb 8. Nature. 2017. PMID: 28178237 Free PMC article.

2

Isolation and regional localization of 25 anonymous DNA probes on a chromosome 13 hybrid panel.

Houwen RH, Pautler SE, Barwell JA, Arden K, Buchanan JA, James CD, Cavenee WK, Buys CH, Cowell JK, Cox DW. Houwen RH, et al. Among authors: cavenee wk. Cytogenet Cell Genet. 1991;57(2-3):87-90. doi: 10.1159/000133120. Cytogenet Cell Genet. 1991. PMID: 1914527

3

The receptors for prolactin and growth hormone are localized in the same region of human chromosome 5.

Arden KC, Boutin JM, Djiane J, Kelly PA, Cavenee WK. Arden KC, et al. Among authors: cavenee wk. Cytogenet Cell Genet. 1990;53(2-3):161-5. doi: 10.1159/000132919. Cytogenet Cell Genet. 1990. PMID: 2369845

4

Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11.

Grundy P, Koufos A, Morgan K, Li FP, Meadows AT, Cavenee WK. Grundy P, et al. Among authors: cavenee wk. Nature. 1988 Nov 24;336(6197):374-6. doi: 10.1038/336374a0. Nature. 1988. PMID: 2848199

5

Loss of P16INK4 expression is frequent in high grade gliomas.

Nishikawa R, Furnari FB, Lin H, Arap W, Berger MS, Cavenee WK, Su Huang HJ. Nishikawa R, et al. Among authors: cavenee wk. Cancer Res. 1995 May 1;55(9):1941-5. Cancer Res. 1995. PMID: 7728764

6

A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma.

Herbst RA, Larson A, Weiss J, Cavenee WK, Hampton GM, Arden KC. Herbst RA, et al. Among authors: cavenee wk. Cancer Res. 1995 Jun 15;55(12):2494-6. Cancer Res. 1995. PMID: 7780954

7

Dinucleotide repeat polymorphism adjacent to CDKN2.

Herbst RA, Nobori T, Cavenee WK, Carson DA, Arden KC. Herbst RA, et al. Among authors: cavenee wk. Hum Mol Genet. 1994 Dec;3(12):2265. doi: 10.1093/hmg/3.12.2265-a. Hum Mol Genet. 1994. PMID: 7881438 No abstract available.

8

Replacement of the p16/CDKN2 gene suppresses human glioma cell growth.

Arap W, Nishikawa R, Furnari FB, Cavenee WK, Huang HJ. Arap W, et al. Among authors: cavenee wk. Cancer Res. 1995 Mar 15;55(6):1351-4. Cancer Res. 1995. PMID: 7882335

9

Loss of heterozygosity for 10q22-10qter in malignant melanoma progression.

Herbst RA, Weiss J, Ehnis A, Cavenee WK, Arden KC. Herbst RA, et al. Among authors: cavenee wk. Cancer Res. 1994 Jun 15;54(12):3111-4. Cancer Res. 1994. PMID: 8205526

10

The RAP1GA1 locus for human Rap1-GTPase activating protein 1 maps to chromosome 1p36.1-->p35.

Weiss J, Rubinfeld B, Polakis PG, McCormick F, Cavenee WK, Arden KC. Weiss J, et al. Among authors: cavenee wk. Cytogenet Cell Genet. 1994;66(1):18-21. doi: 10.1159/000133655. Cytogenet Cell Genet. 1994. PMID: 8275700

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

339 results

Search Page

Filters